Rubicon Research Ltd
NSE: RUBICON BSE: 544578
₹960.95
(0.49%)
Wed, 27 May 2026, 05:52 pm
Market Cap158.91B
PE Ratio0
Dividend0
Health Technology
Biotechnology
24.5KRubicon Research Financials
| Particulars | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total revenue | 3.10B | 3.91B | 8.48B | 12.74B |
| Gross profit | 833.59M | 1.03B | 3.51B | 5.82B |
| Operating expenses (excl. COGS) | -1.59B | -1.21B | -2.37B | -3.70B |
| Selling/general/admin expenses, total | -1.59B | -1.21B | -2.31B | -3.65B |
| Research & development | -1.83B | -988.73M | -1.52B | -538.35M |
| Selling/general/admin expenses, other | 238.48M | -218.13M | -786.41M | -3.11B |
| Other operating expenses, total | -1.44M | -5.96M | -68.23M | -48.90M |
| Operating income | -760.37M | -182.80M | 1.14B | 2.12B |
| Non-operating income, total | 99.25M | 72.31M | -110.65M | -172.02M |
| Interest expense, net of interest capitalized | -97.23M | -179.51M | -303.67M | -329.30M |
| Interest capitalized | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 196.48M | 251.82M | 193.02M | 157.29M |
| Non-operating interest income | 18.60M | 11.26M | 16.26M | 15.23M |
| Miscellaneous non-operating expense | 177.88M | 240.56M | 176.76M | 142.06M |
| Unusual income/expense | 0 | 0 | 0 | 0 |
| Pretax income | -661.12M | -110.49M | 1.03B | 1.95B |
| Taxes | -10.06M | -58.39M | -118.45M | -601.62M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | -671.18M | -168.88M | 910.12M | 1.34B |
| Net income | -671.18M | -168.88M | 910.12M | 1.34B |
| Dilution adjustment | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | -671.18M | -168.88M | 910.12M | 1.34B |
| Basic earnings per share (Basic EPS) | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - |
| EBITDA | -420.30M | 177.81M | 1.53B | 2.48B |
| EBIT | -760.37M | -182.80M | 1.14B | 2.12B |
| Total operating expenses | -3.87B | -4.09B | -7.34B | -10.62B |
| Prepaid expenses | 119.64M | 168.58M | 422.27M | 546.01M |
| Deferred income, current | 1.30M | 1.29M | 23.81M | 17.38M |
| Capital and operating lease obligations | 15.61M | 0 | 220.36M | 165.74M |
| Operating lease liabilities | — | — | — | — |
| Deferred tax liabilities | 39.04M | 14.54M | — | — |
| Deferred income, non-current | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 6.00K |
| Change in accrued expenses | — | — | — | — |
| Common dividends paid | -5.07M | -2.54M | -2.54M | -3.04M |
| Preferred dividends paid | 0 | 0 | 0 | 0 |